Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
The combination also yielded durable responses in a subset of patients with sporadic papillary renal cell carcinoma.
Hong Truong, MD, MS, details key findings on referrals for genetic counseling among patients with kidney cancer who meet the criteria for genetic evaluation.
Clinical trials still have a role in improving outcomes with immunotherapy among those with kidney cancer.
Panelists discuss how the CheckMate 214 study demonstrated durable overall survival benefits with ipilimumab plus nivolumab vs sunitinib, with 9-year follow-up showing improved outcomes even in favorable-risk patients and nearly half of responders remaining in remission.
Panelists discuss how clear cell renal cell carcinoma (RCC) represents the most common kidney cancer subtype, typically affecting men in their 50s and 60s who often present incidentally with metastatic disease, and has limited identifiable risk factors beyond smoking, hypertension, and obesity.
In a groundbreaking leap forward for cancer immunotherapy, researchers at UCLA have engineered a novel cell therapy designed to confront one of the most stubborn and deadly cancers: metastatic renal
Boris M. Kiselev, MD, provides practical advice for oncology clinicians on how to approach and initiate conversations about a patient’s mental and emotional well-being.
Boris M. Kiselev, MD, explores evidence-based interventions for managing cancer-related anxiety and depression.
Renal cell carcinoma (RCC) is a common urological tumor, with clear cell renal cell carcinoma (ccRCC) being the most prevalent subtype. Metabolic reprogramming plays a critical role in ccRCC progression, making it a promising target for therapeutic intervention, though effective treatments ...
... renal cell carcinoma (RCC). However, its u ... renal cell carcinoma with inferior vena cava tumor thrombus and multiple metastases.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.